View Author
cancer 0.00 patient -01 expression tumor breast hsa-mir sample mirna 0.01 breast cancer score analysis study level tamoxifen pathway cluster -02 prognostic signature exemestane dataset activation therapy survival transcript bene fit vegf-a value research receptor american association correlation outcome profile table tumor cells cancer research -03 epithelial pgr expression metastatic treatment blood 5 ctcs ratio leukocyte assay effect 1.0 trial 0.02 oncol oncology oncology information downloaded john m.s cellsearch april method american society onlinefirst tissue 0.05 reference -04 preamplification clin cancer res group prognostic value control pathology downloaded survival outcome recurrence hrec expression copyright huvec
3 Most Recent Publications
|
Microarray-Based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma
(Article)
Trinh, X.B. Tjalma, W.A.A. Dam, P.A. van Dirix, L. Vermeulen, P.B. Peeters, D. Bachvarov, D. Plante, M. Berns, P.M.J.J. Helleman, J. Laere, S.J. van |
2011-07-29
|
|
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients
(Article)
Sieuwerts, A.M. Mostert, B. Kraan, J. Spoel, P. van der Ramírez-Moreno, R. Deurzen, C.H.M. van Smid, M. Yu, J.X. Jiang, J. Wang, Y. Gratama, J-W. Sleijfer, S. Bolt-de Vries, J. Foekens, J.A. Martens, J.W.M. Peeters, D. Jongh, F.E. de Stouthard, J.M.L. Dirix, L. Dam, P.A. van Galen, A. van Weerd, V. de |
2011-06-01
|
|
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: A prospectively powered pathology study in the tamoxifen and exemestane adjuvant multinational trial
(Article)
Bartlett, J.M.S. Brookes, C.L. Kieback, D.G. Putter, H. Markopoulos, C. Kranenbarg, E.M.-K. Mallon, E.A. Dirix, L. Seynaeve, C.M. Rea, D. Robson, T. Velde, C.J.H. van de Billingham, L.J. Campbell, F.M. Grant, M. Hasenburg, A. Hille, E.T. Kay, C. |
2011-04-20
|
